Title : Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer.

Pub. Date : 2014 Apr 30

PMID : 24781822






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Additionally, SLC6A6-siRNA treatment enhanced the cytotoxic effects of all 3 drugs, whereas the efficacy of ABCG2-siRNA treatment was limited to its 2 substrate drugs, DOX and SN-38. Irinotecan ATP binding cassette subfamily G member 2 (Junior blood group) Homo sapiens